<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">

    <channel>
    
    <title>Biotica News</title>
    <link>http://www.biotica.com/index.php/biotica/news_article</link>
    <description>The latest news from Biotica Technology Ltd</description>
    <dc:language>en</dc:language>
    <dc:rights>Copyright 2010</dc:rights>
    <dc:date>2010-07-08T09:00:43+00:00</dc:date>
    <admin:generatorAgent rdf:resource="http://expressionengine.com/" />
    

    <item>
      <title>Biotica consolidates leadership in polyketide therapeutics and extends platform</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_consolidates_leadership_in_polyketide_therapeutics_and_extends_plat/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_consolidates_leadership_in_polyketide_therapeutics_and_extends_plat/#When:09:00:43Z</guid>
      <description>Cambridge, UK: 8 July 2010 Biotica announces its consolidation of the polyketide engineering intellectual property (IP) space, via acquisition of IP from Bristol&#45;Myers Squibb Company&#8230;</description>
      <dc:date>2010-07-08T09:00:43+00:00</dc:date>
    </item>

    <item>
      <title>Biotica achieves preclinical proof&#45;of&#45;concept in its nPT&#45;CyP hepatitis C programme</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_achieves_preclinical_proof-of-concept_in_its_npt-cyp_hepatitis_c_pr/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_achieves_preclinical_proof-of-concept_in_its_npt-cyp_hepatitis_c_pr/#When:07:54:25Z</guid>
      <description>Cambridge, UK: 6 April 2010 Biotica today announces that nPT&#45;CyP, its non&#45;cyclosporin cyclophilin (CyP) inhibitor programme for the treatment of hepatitis C virus (HCV), has reached&#8230;</description>
      <dc:date>2010-04-06T07:54:25+00:00</dc:date>
    </item>

    <item>
      <title>Dr. Edward Hodgkin elected to the Board of Directors of BIA</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/dr._edward_hodgkin_elected_to_the_board_of_directors_of_bia/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/dr._edward_hodgkin_elected_to_the_board_of_directors_of_bia/#When:11:33:49Z</guid>
      <description>28 October&#8230;</description>
      <dc:date>2009-10-28T11:33:49+00:00</dc:date>
    </item>

    <item>
      <title>Biotica achieves preclinical proof&#45;of&#45;concept in nPT&#45;CLN asthma programme</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_achieves_preclinical_proof-of-concept_in_npt-cln_asthma_programme/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_achieves_preclinical_proof-of-concept_in_npt-cln_asthma_programme/#When:07:30:44Z</guid>
      <description>Cambridge UK: 2 October 2009 Biotica, the leader in discovery of polyketide therapeutics, today announces that it has reached preclinical proof&#45;of&#45;concept in its nPT&#45;CLN programme for&#8230;</description>
      <dc:date>2009-10-02T07:30:44+00:00</dc:date>
    </item>

    <item>
      <title>Biotica alliance with GSK shortlisted for prestigious Scrip Award</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_alliance_with_gsk_shortlisted_for_prestigious_scrip_award/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_alliance_with_gsk_shortlisted_for_prestigious_scrip_award/#When:11:25:59Z</guid>
      <description>Cambridge UK, 11 September 2009 Biotica, the leader in the discovery of polyketide therapeutics, has been shortlisted for the 2009 Scrip Award for Licensing Deal of the Year. In previous&#8230;</description>
      <dc:date>2009-09-11T11:25:59+00:00</dc:date>
    </item>

    <item>
      <title>Biotica adds nPT&#45;CyP, a series of polyketide cyclophilin inhibitors for HCV, to its pipeline</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_adds_bpt-cyp_a_series_of_polyketide_cyclophilin_inhibitors_for_hcv_/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_adds_bpt-cyp_a_series_of_polyketide_cyclophilin_inhibitors_for_hcv_/#When:07:30:18Z</guid>
      <description>Cambridge, UK: 25 June 2009 Biotica, the leader in discovery of polyketide therapeutics, today announces the progression of the nPT&#45;CyP project into its pipeline. The series of non&#45;cyclosporin&#8230;</description>
      <dc:date>2009-06-25T07:30:18+00:00</dc:date>
    </item>

    <item>
      <title>Dr Alan Lewis joins Biotica Board</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/dr_alan_lewis_joins_biotica_board/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/dr_alan_lewis_joins_biotica_board/#When:09:26:14Z</guid>
      <description>Cambridge, UK: 26 May 2009 Biotica Technology Ltd, the leader in discovery of polyketide therapeutics, today announced the appointment of Dr Alan Lewis as a Non&#45;Executive Director&#8230;</description>
      <dc:date>2009-05-26T09:26:14+00:00</dc:date>
    </item>

    <item>
      <title>Biotica strikes significant collaboration deal with GlaxoSmithKline</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_strikes_significant_collaboration_deal_with_glaxosmithkline1/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_strikes_significant_collaboration_deal_with_glaxosmithkline1/#When:09:46:44Z</guid>
      <description>Cambridge UK: 12 January&amp;nbsp;2009 Biotica Technology Limited, a privately&#45;held biotechnology company, announces a significant Collaboration and License Agreement with GlaxoSmithKline&#8230;</description>
      <dc:date>2009-01-12T09:46:44+00:00</dc:date>
    </item>

    <item>
      <title>Biotica appoints Edward E. Hodgkin as CEO</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/biotica_appoints_edward_e._hodgkin_as_ceo/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/biotica_appoints_edward_e._hodgkin_as_ceo/#When:10:50:08Z</guid>
      <description>Cambridge UK: 12 September&amp;nbsp;2007 Biotica Technology Limited (Biotica), a privately held drug discovery company focused on novel &amp;ldquo;polyketide&amp;rdquo; drugs, announced today the&#8230;</description>
      <dc:date>2007-09-12T10:50:08+00:00</dc:date>
    </item>

    <item>
      <title>Dr Peter Ringrose joins Biotica Board</title>
      <link>http://www.biotica.com/index.php/biotica/news_article/dr_peter_ringrose_joins_biotica_board/</link>
      <guid>http://www.biotica.com/index.php/biotica/news_article/dr_peter_ringrose_joins_biotica_board/#When:10:53:59Z</guid>
      <description>Cambridge&amp;nbsp;UK: 5 September, 2007 Biotica Technology Ltd, a privately held biotechnology company, today announced the appointment of Dr Peter Ringrose as&#8230;</description>
      <dc:date>2007-09-05T10:53:59+00:00</dc:date>
    </item>

    
    </channel>
</rss>